[New York] Specialty pharmacy precertification list expands
Summary
Anthem Blue Cross and Blue Shield (New York) is expanding its specialty pharmacy precertification requirements for Medicare Advantage plans. Effective January 1, 2027, step therapy will be added to the precertification review process for 10 Part B medications (denosumab, bendamustine, and pemetrexed formulations). Additionally, effective February 1, 2027, three new Part B drugs (golimumab-sldi, bevacizumab-vikg, and isatuximab-irfc) will be included in the precertification review process. Noncompliance with these requirements may result in claim denial.
Get alerts when payers change rules like this one
We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.